The clinical paper entitled "Prognostic value of circulating H3K27Me3-nucleosomes in newly diagnosed lung cancer patients: Real-world evidence1" has been written in conjunction with researchers and clinicians at the Hospices Civils de Lyon (HCL), France's second largest university hospital system, and is currently under peer review.